Literature DB >> 26168246

Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) intraindividual variability in older adults: Associations with disease and mortality.

Nicholas S Thaler1, Benjamin D Hill, Kevin Duff, James Mold, James G Scott.   

Abstract

UNLABELLED: Cognitive intraindividual variability (IIV), or dispersion, has been associated with pathological changes, including cognitive and functional decline. Dispersion is typically assessed with experimental cognitive measures or subtests selected from several batteries, and few studies have examined IIV from a single neuropsychological battery.
METHOD: To address this gap, the current study examined the relationship between the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) IIV, mean cognitive performance, self-reported functioning, and death among 699 individuals between 64 and 94 years of age who were screened for neurological illness and living independently in the community. A coefficient of variation statistic served as the dispersion index and was derived by calculating the within-subject variability of the five RBANS indexes for each participant and dividing this value by the overall test battery mean.
RESULTS: Results revealed that increased dispersion and poorer mean performance simultaneously predicted self-reported memory problems. In addition, participants with elevated dispersion at baseline had increased rates of death nine years later, although this lost significance after controlling for comorbid heart disease. Cluster analysis of the higher dispersion scores revealed four distinct profile patterns that did not differ on the outcome variables.
CONCLUSIONS: Elevated RBANS dispersion is a proxy of co-occurring health problems and may be a useful metric of functional decline and death within community-dwelling geriatric populations.

Entities:  

Keywords:  Coefficient of variation; Dispersion; Geriatric; Mortality; Repeatable Battery for the Assessment of Neuropsychological Status

Mesh:

Year:  2015        PMID: 26168246     DOI: 10.1080/13803395.2015.1039962

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  7 in total

1.  Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.

Authors:  Dustin B Hammers; Taylor J Atkinson; Bonnie C A Dalley; Kayla R Suhrie; Britney E Beardmore; Lance D Burrell; Kevin P Horn; Kelli M Rasmussen; Norman L Foster; Kevin Duff; John M Hoffman
Journal:  Clin Neuropsychol       Date:  2017-01-12       Impact factor: 3.535

2.  Intraindividual variability in neurocognitive performance is associated with time-based prospective memory in older adults.

Authors:  Kelli L Sullivan; Steven Paul Woods; Romola S Bucks; Shayne Loft; Michael Weinborn
Journal:  J Clin Exp Neuropsychol       Date:  2018-02-20       Impact factor: 2.475

3.  Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer's disease.

Authors:  Kevin Duff; Kayla R Suhrie; Dustin B Hammers; Ava M Dixon; Jace B King; Vincent Koppelmans; John M Hoffman
Journal:  Clin Neuropsychol       Date:  2021-10-29       Impact factor: 4.373

4.  Cognitive dispersion and ApoEe4 genotype predict dementia diagnosis in 8-year follow-up of the oldest-old.

Authors:  Tam Watermeyer; Jantje Goerdten; Boo Johansson; Graciela Muniz-Terrera
Journal:  Age Ageing       Date:  2021-05-05       Impact factor: 10.668

5.  No effect of thyroid hormones on 5-year mortality in patients with subjective cognitive decline, mild cognitive disorder, and Alzheimer's disease.

Authors:  Blaž Đapić; Eva Schernhammer; Helmuth Haslacher; Elisabeth Stögmann; Johann Lehrner
Journal:  J Neuroendocrinol       Date:  2022-02-25       Impact factor: 3.870

6.  A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment.

Authors:  Libby A DesRuisseaux; Victoria J Williams; Alison J McManus; Anoopum S Gupta; Becky C Carlyle; Hamed Azami; Jessica A Gerber; Anna M Bolling; Carolyn L Cook; Rebecca A Betensky; Steven E Arnold
Journal:  Trials       Date:  2020-12-11       Impact factor: 2.279

7.  Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial.

Authors:  Michelle Gray; Erica N Madero; Joshua L Gills; Sally Paulson; Megan D Jones; Anthony Campitelli; Jennifer Myers; Nicholas T Bott; Jordan M Glenn
Journal:  JMIR Res Protoc       Date:  2022-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.